Dr. Daniel R. Nathanson, MD

Dr. Nathanson practices at The San Francisco Vein and Vascular Institute, LLC in San Francisco, California.

Dr. Nathanson's NPI, 1467653006, was assigned on May 30, 2007. Dr. Nathanson graduated from Penn State College of Medicine in 1997. Dr. Nathanson holds California license A91712.

Dr. Nathanson's primary practice is The San Francisco Vein and Vascular Institute, LLC, at 2250 Hayes St, San Francisco, CA 94117 in San Francisco County. The practice phone is (415) 221-7056.

Dr. Nathanson's primary practice is The San Francisco Vein and Vascular Institute, LLC in San Francisco, California. Dr. Nathanson is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is BASS Medical Group. Dmand AI also links Dr. Nathanson to 4 more hospitals, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nathanson practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Nathanson's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Nathanson is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Nathanson's licenses on file in 2 states: California and Arizona.

Dmand AI lists aortic atherosclerois, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Nathanson treats.

CMS data shows 1,852 Medicare services from Dr. Nathanson across 22 procedure codes in 2024, for 421 Medicare patients. Medicare paid $329,359 for them.

CMS counts 421 Medicare patients who saw Dr. Nathanson in 2024. The largest group is 75 to 84, with 179 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nathanson's median patient age at 76, with 47% women.

In 2024, Dr. Nathanson wrote 274 Medicare Part D claims for 77 patients. 71% of them were for generic drugs. CMS names the drug for 236 of them, across 3 drugs with 11 or more claims each, at $62,400 in total drug cost. In 2023, CMS named 191 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Nathanson for performance year 2024, reported through an alternative payment model (APM). Dr. Nathanson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nathanson as offering telehealth. CMS counts 56 procedures of leg revascularization (restoring blood flow) by Dr. Nathanson, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Nathanson in 2009. 2009 was the busiest year, with 2. The most frequent topics are Adenocarcinoma, Colorectal Neoplasms and Liver Neoplasms. Dr. Nathanson has published most often in Ann Surg Oncol. Dr. Nathanson's most frequent co-authors are Garrett Michael Nash, MD, Philip B. Paty, MD and Bruce D. Minsky, MD.

CMS Open Payments shows 291 general payments to Dr. Nathanson from 28 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 53% of the total. AngioDynamics, Inc. paid the most, $16,485.

Dr. Nathanson graduated from Penn State College of Medicine in 1997.

Dr. Nathanson is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.